Memorial Sloan Kettering Cancer Center is the world’s oldest and largest private cancer center, having devoted more than 130 years to exceptional patient care, innovative research, and outstanding educational programs.

The following facts and figures reflect our reputation for scientific excellence and our commitment to finding better approaches to preventing, diagnosing, and treating cancer.

Who We Are

  • Recognized Nationally – The National Cancer Institute has designated MSK as one of only 41 comprehensive cancer centers in the country, underscoring our multidisciplinary cancer research program, expert faculty, and state-of-the-art facilities.
  • Clinical Staff – Our staff of 12,975 dedicated and talented employees includes 935 attending physicians and 2,221 registered nurses.
  • Researchers – We have 143 senior laboratory investigators, 323 research fellows, 547 postdoctoral researchers, and 246 graduate students (both PhDs and MD/PhDs).
  • Educators – Our always-evolving educational programs continue to train new leaders in the field, here and around the world. In 2013, we trained 1,691 residents and clinical fellows; 547 postdoctoral research fellows, research scholars, and research associates; 227 PhD candidates; 19 MD/PhD candidates; 179 nursing students; and 392 medical students.

Patient Care

  • Teamwork – We take a unified approach to cancer care, with more than 20 Disease Management Teams of multidisciplinary specialists who work together to guide each patient through diagnosis, treatment, and recovery. Our specially trained oncology nurses work closely with our physicians to provide compassionate, patient-centered care, foster a safe and healing environment, and offer support and comfort to our patients and their loved ones.
  • SpecializationOur physicians treat more than 400 different subtypes of cancer each year, rendering a level of specialization that can have an often dramatic effect on our patients’ chances for a cure or control of their disease. Our nurses bring extraordinary knowledge, experience, and expertise to the care they give to people with cancer treated here.
  • PathologyOur pathologists analyze more than 40,000 tumor samples each year to determine a precise diagnosis and the extent of disease (called staging) — an essential step in deciding the best course of treatment.
  • Screening – Some 12,826 cancer screenings were performed at MSK in 2013. MSK’s Breast Examination Center of Harlem has screened more than 200,000 women for breast cancer at no cost to those screened since it opened in 1979.
  • Our Patients – In 2013, nearly 137,000 patients were seen at all of MSK’s locations, with 22,326 admitted to Memorial Hospital. Our Manhattan and suburban outpatient treatment centers also accommodated 571,922 outpatient visits.

Research and Discovery

  • Scientific Excellence – Our investigators include 12 members of the National Academy of Sciences, 17 Institute of Medicine members, one National Medal of Science winner, eight Howard Hughes Medical Institute investigators, two Lasker Award recipients, one winner of the Breakthrough Prize in Life Sciences, and one winner of the Wolf Prize in Chemistry.
  • Biomedical Research – We are one of the nation’s leading centers for biomedical research, bringing together scientists and physicians to solve critical problems in cancer biology and human health.
  • Drug Development – To date, research conducted at Memorial Sloan Kettering has produced nine drugs that have been approved by the FDA for marketing, and one product approved by the US Department of Agriculture — a success rate unmatched by any other cancer center. In fact, a 2011 study ranked MSK as one of the top three public-sector research organizations in the discovery of new therapeutic products, after the National Institutes of Health’s intramural program and the ten-campus University of California.
  • Basic and Translational Research – Our basic laboratory research activities are organized around eight major research programs focused on advancing knowledge in the biomedical sciences and making discoveries aimed at improving our understanding of cancer and ultimately benefiting patients. We also have an extensive hospital research program in which our scientists focus on translational research that bridges discoveries made in the laboratory and those made in the clinic, as well as on mathematical and computational research directed at analyzing and interpreting biomedical data.
  • Clinical Research – We conduct one of the largest clinical research programs in the world, aimed at improving the prevention, diagnosis, and treatment of cancer. In December 2013, our physicians were leading 1,259 clinical research studies for pediatric and adult cancers.
  • Collaborative Research – Drawing on the breadth of its scientific expertise, MSK brings together laboratory investigators and clinicians from different disciplines within our institution to create centers without walls that focus on key areas in cancer research. Moreover, our investigators work with scientists from other institutions — such as the Broad Institute of MIT and Harvard, Cold Spring Harbor Laboratory, The Rockefeller University, Weill Cornell Medical College, and City College of New York — allowing us to gain valuable insight from researchers who are also exploring new ways to cure, control, and prevent disease.

Education and Training

  • Leading in Life Sciences and Medicine – A vital part of our mission, our training, graduate, and continuing education programs prepare the next generation of physicians, scientists, nurses, and other healthcare professionals for leadership roles in the life sciences and medicine, especially as related to cancer.
  • Partnering with Top Institutions – Our educational collaborations with The Rockefeller University, Cornell University, and Weill Cornell Medical College offer PhD programs in chemical biology, computational biology and medicine, and the medical sciences. MSK also partners with Weill Cornell Medical College and The Rockefeller University to offer an MD/PhD program for aspiring physician-scientists.
  • Preparing Basic Scientists – The Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences offers a PhD degree in cancer biology, training gifted basic laboratory scientists to work in research areas directly relevant to cancer and other human diseases. We also offer postdoctoral research fellowships that provide scientists with advanced laboratory research training.
  • Educating Physicians – We offer postgraduate clinical fellowships to train physicians who seek special expertise in a particular type of cancer. With faculty appointments at the Weill Cornell Medical College, our clinical staff members also train residents and medical students.
  • Committing to Nurses – We are committed to improving the quality of care for people with cancer through the professional development and education of nurses at MSK. We value their efforts to achieve advanced degrees and national certifications in their specialty practices, keep pace with technological and scientific advances in oncology nursing, and play leadership roles in the ongoing development of the profession.
  • Training the Next Generation – We offer a variety of educational and training programs for high school and college students who aspire to careers in medicine and science. These programs include the Summer Undergraduate Research Program, a ten-week research program for outstanding undergraduate students who are interested in pursuing a career in the biomedical sciences; the School of Cytotechnology, a one-year post-baccalaureate certificate program that provides students with a wide range of technical and cytodiagnostic skills; and the School of Radiation Therapy, which offers a two-year, full-time program of study in Radiation Oncology Technology.

How We Rank

  • Best Hospitals – U.S. News & World Report ranked Memorial Sloan Kettering the number one hospital for cancer care in the country and among the nation’s top pediatric hospitals for cancer in its 2014-2015 rankings.
  • With Our Patients – According to our most recent patient satisfaction survey, we received an average overall hospital rating of 90 out of 100 among inpatients and an overall care and service rating of 96 out of 100 among outpatients.
  • Cancer Survival Outcomes – Quality of patient care is of paramount importance at MSK, where patient survival outcomes are better than the national average, according to the National Cancer Data Base, which contains data from more than 1,400 hospitals across the United States.
  • Among Employers – Becker’s Hospital Review named MSK one of the “150 Great Places to Work in Healthcare” for 2014.
  • Among National Charities – Forbes named MSK among the 50 largest US charities in 2013.
  • With Hospital Technology – Hospitals & Health Networks named MSK among the country’s most wired hospitals and health systems in the United States for the tenth year in a row in 2014.
  • With Published Research — Sixteen MSK researchers were named among the “World’s Most Influential Scientific Minds: 2014” in a report compiled by Thomson Reuters that features investigators who have published the highest number of articles most frequently cited by their peers.
  • Performance Improvement – Our nurses set standards and influence decisions concerning quality of care, taking the lead with other quality experts in developing nationally recognized best practices to improve quality of care and patient outcomes. For example, our nursing leadership is responsible for taking steps to significantly reduce or eliminate incidences of preventable events — such as patient falls and related injuries, infections, skin pressure ulcers (bed sores), and extraversions (the inadvertent administration of chemotherapy into healthy tissue surrounding tumors).

Where We Work

  • Memorial Hospital – We are well-known for our hospital location on the Upper East Side of Manhattan, where we have 471 inpatient beds, 21 state-of-the-art surgical suites, and a world-renowned children’s hospital. We also have many administrative, technical, and support staff members who work in six nonclinical and administrative buildings in Manhattan and in Lyndhurst, New Jersey.
  • Outpatient Facilities – We have outpatient locations throughout Manhattan and one in Brooklyn, as well as suburban outpatient treatment centers in Commack, NYHauppauge, NYRockville Centre, NY; and Basking Ridge, NJ. In October 2014, we opened a suburban outpatient treatment center in West Harrison, NY. A New Jersey facility in Middletown will be fully operational by the winter of 2016. 
  • Research Laboratories – We have more than 120 research laboratories in Manhattan that are focused on better understanding cancer, and more than 35 state-of-the-art core facilities that provide our research community with the latest technologies and a wide range of expert services.

How We Are Supported

  • Philanthropy – MSK received more than $380 million in philanthropic support in 2013, an all-time high for the institution.
  • Capital Campaign – A Capital Campaign for Memorial Sloan Kettering was launched in 2003 with an original goal of raising $1 billion over five years. Given its early success, the campaign has been extended to a historic fund-raising effort and its goal is now $3.5 billion. As of December 31, 2013, gifts and pledges totaled more than $3.1 billion.
  • Grants and Contracts – We received $202 million in grants and contracts to support our research in 2013.
  • Volunteers – More than 1,000 volunteers generously donated nearly 80,000 hours of service in 2013.